Start Date: 15-June-2011
Schedule:
June 15-16, 2011
Location:
Faegre & Benson LLP
1700 Lincoln Street Suite 3200
Denver, CO 80203.
Faegre & Benson LLP and the Colorado Bioscience Association are pleased to present the 2011 Rocky Mountain BioBooster. This 2-day program is specifically designed to address critical issues facing mid-stage life sciences and medical device companies.
Topics that will be covered include:
- Characteristics of a Successful Mid-Stage Company Business Model,
- Best Practices for Product Development, Clinical Trials, and Manufacturing,
- How to Fund the Next Stage of Development,
- Managing a Patent Portfolio and Controlling Outside Legal Costs,
- Developing and Executing an IP Licensing Strategy,
- How to Attract and Deal with Strategic Partners and Investors,
- Anatomy of a Partnering Deal,
- Mock Licensing Negotiation Exercise, and
- Considerations for Becoming a Public Company.
The Rocky Mountain BioBooster will feature panelists and speakers that are experienced entrepreneurs, investors and practitioners from:
- ARCA biopharma
- Ariel Pharmaceuticals
- Biodesix
- Boulder Ventures
- CID4
- Colorado State University
- DCS Surgical
- Flextronics Medical
- LLC Consulting
- National Jewish Health
- OPX Biotechnologies
- Roche Colorado
- Regulatory & Clinical Research Institute
- SomaLogic
- Sandhill Scientific
- University of Colorado
- ValveXChange
- And more!
The target audience is management and technical personnel from companies that:
(1) Have at least 10 employees,
(2) Have received seed financing, and
(3) Are in early- to mid-stages of clinical development.
You are encouraged to apply even if you do not necessarily meet each of these criteria.
The program is free for CBSA members and is $50 per person for non-members.
Seating is limited so we request that you limit your company participation to a maximum of two attendees. Applications are reviewed as received, and you will be notified if you are placed on the waiting list.
Please click here to apply by Friday, June 10, 2011.